Directors report | Business review Chairmans statement Croda has delivered an unbroken run of continuing sales and profit growth for over ten years.
This is a testament to the focus on a clear strategy which is communicated and executed throughout the business.
This year has seen record results, with strong Martin Flower Non-executive Chairman demand, tight cost control and the benefits of past restructuring producing the uplift.
Full Year Results Return on sales increased to 12.8% 2009: 4.8%, beating our previous 10% Record turnover and profits were achieved target and making good progress towards in 2010. the new, more challenging 15% goal.
Turnover was over 1 billion for the first Cash flow was again very impressive with time at 1,001.9m, up 21.1% on 2009s a 68.2m reduction in net debt.
Pre-tax profits increased 78.1% drove the result, which was achieved to 192.3m 2009: 108.0m.
Continuing despite a working capital increase as earnings per share were up 77.3% at activity levels rose dramatically.
Demand was strong in all business Disposals and Acquisitions areas within both sectors and across We continue to streamline the business all major geographies.
Latin America, and focus on high value speciality Asia and Africa accounted for 32.4% of products.
Group turnover and that does not include On 10 May 2010 we announced that we ingredients we sell in Europe and America had agreed to sell the Emmerich site where our customers export finished and associated business in Germany to products to consumers in those markets.
KLK Emmerich GmbH, a subsidiary of the Consumer Care turnover was up 14.0% to KLK Group, for 55.0m.
All business transaction, the purchaser assumed the areas recorded at least double digit IAS 19 retirement benefit obligations growth, with Personal Care and Crop relating to the business of 38.4 million Care leading the way.
Operating profit so that cash payable at completion was increased 31.8% to 136.5m 2009: 16.6m.
There was an exceptional profit Turnover was 103.6m.
before tax on the sale of 0.9m.
over 1 billion Industrial Specialities turnover was up In November 2010 we bought out our for the first 29.7% to 485.5m 2009: 374.4m.
Our joint venture partners 40% share in our strategy to focus on lower volume, high time Indonesian company for $1.6m.
Since specification, high quality ingredients the year end we have sold our 60% to our five markets was central to our shareholding in the Korean joint venture progress.
This further benefitted the to the non-controlling shareholders for operating profit where profits rose 2.2m.
market for Croda and our sales, distribution and technical operations The first half of 2009 had been adversely in the country are unaffected by the affected by customer destocking as a disposal.
result of the recession but nevertheless this was a very pleasing result.
All these businesses were acquired with Uniqema in 2006.
3 Retirement Benefits Our gross IAS 19 pension deficit reduced We expect to increase capital expenditure from 203.5m to 147.8m.
The sale of in 2011 to a higher level than that seen in Emmerich in May 2010 was the biggest recent years in order to increase capacity, element of the reduction as it removed but there is a limit to what can be spent almost all of our pension liabilities in in any one year without disrupting Germany.
The deficit was then further operations.
reduced in 2010 by additional Company Despite this increase, we expect to contributions and increased asset values generate a significant amount of cash in from stronger global equity markets 2011 and with our net debt to EBITDA outweighing increased liabilities as a ratio already below one times, we believe consequence of slightly lower corporate that returning excess cash to shareholders bond rates.
by resuming our share buyback programme is a logical move.
We see the Dividend programme as tactical and continue to Given the strong performance across all monitor suitable acquisition opportunities.
our businesses, the Board will propose an In the absence of such acquisitions, we increase in the final dividend of 68.3% would expect to buy shares worth around to 25.25p 2009: 15.0p.
This will give a 50m in the market over the next year.
total dividend for the year of 35.0p, up 62.8% on 2009s 21.5p.
Outlook The strong trading performance during the As a business, we Share Buyback fourth quarter has continued into 2011.
With Crodas performance and prospects seek to provide We are continuing to see significant raw being so strong it makes sense to our customers with material inflation and have increased our maximise our investment in the prices as we entered the year to protect products that meet business through capital expenditure and our profitability.
Across both Consumer acquisitions where appropriate.
market demands and, Care and Industrial Specialities, our global wherever possible, markets continue to grow and we are confident of making further progress in with environmentally the current year.
friendly solutions Martin Flower Chairman Crodas Polymer Additives business launched Atmer 7510 in 2010.
This additive provides several benefits to customers using recycled PET plastics, including increased product quality and energy savings due to more efficient processing.
